These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 8224130)

  • 1. Distearoyl phosphatidylglycerol liposomes improve surface and transport properties of CF mucus.
    Girod de Bentzmann S; Pierrot D; Fuchey C; Zahm JM; Morançais JL; Puchelle E
    Eur Respir J; 1993 Sep; 6(8):1156-61. PubMed ID: 8224130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent in vitro effect of recombinant human DNase on rheological and transport properties of cystic fibrosis respiratory mucus.
    Zahm JM; Girod de Bentzmann S; Deneuville E; Perrot-Minnot C; Dabadie A; Pennaforte F; Roussey M; Shak S; Puchelle E
    Eur Respir J; 1995 Mar; 8(3):381-6. PubMed ID: 7789481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved clearability of cystic fibrosis sputum with dextran treatment in vitro.
    Feng W; Garrett H; Speert DP; King M
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):710-4. PubMed ID: 9517580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of rhDNase on rheologic properties and transport capacity of mucus in cystic fibrosis].
    Puchelle E; Zahm JM
    Arch Pediatr; 1995 Jul; 2(7):670-3. PubMed ID: 7663658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of human respiratory epithelium from Pseudomonas aeruginosa adherence by phosphatidylglycerol liposomes.
    Girod de Bentzmann S; Bajolet-Laudinat O; Dupuit F; Pierrot D; Fuchey C; Plotkowski MC; Puchelle E
    Infect Immun; 1994 Feb; 62(2):704-8. PubMed ID: 8300228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of cystic fibrosis airway mucus transportability by recombinant human DNase is related to changes in phospholipid profile.
    Zahm JM; Galabert C; Chaffin A; Chazalette JP; Grosskopf C; Puchelle E
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1779-84. PubMed ID: 9620905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucus structure and properties in cystic fibrosis.
    Rubin BK
    Paediatr Respir Rev; 2007 Mar; 8(1):4-7. PubMed ID: 17419972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of inhaled dry powder mannitol on mucus and its clearance.
    Daviskas E; Rubin BK
    Expert Rev Respir Med; 2013 Feb; 7(1):65-75. PubMed ID: 23362816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic fibrosis and other respiratory diseases of impaired mucus clearance.
    Livraghi A; Randell SH
    Toxicol Pathol; 2007 Jan; 35(1):116-29. PubMed ID: 17325980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy.
    App EM; King M; Helfesrieder R; Köhler D; Matthys H
    Am Rev Respir Dis; 1990 Mar; 141(3):605-12. PubMed ID: 2310093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical and functional properties of airway secretions in cystic fibrosis--therapeutic approaches.
    Puchelle E; de Bentzmann S; Zahm JM
    Respiration; 1995; 62 Suppl 1():2-12. PubMed ID: 7792436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A glycopolymer improves vascoelasticity and mucociliary transport of abnormal cystic fibrosis mucus.
    Fernandez-Petty CM; Hughes GW; Bowers HL; Watson JD; Rosen BH; Townsend SM; Santos C; Ridley CE; Chu KK; Birket SE; Li Y; Leung HM; Mazur M; Garcia BA; Evans TIA; Libby EF; Hathorne H; Hanes J; Tearney GJ; Clancy JP; Engelhardt JF; Swords WE; Thornton DJ; Wiesmann WP; Baker SM; Rowe SM
    JCI Insight; 2019 Apr; 4(8):. PubMed ID: 30996141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic aerosols and airway secretions.
    Rubin BK
    J Aerosol Med; 1996; 9(1):123-30. PubMed ID: 10160202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study.
    Robinson M; Daviskas E; Eberl S; Baker J; Chan HK; Anderson SD; Bye PT
    Eur Respir J; 1999 Sep; 14(3):678-85. PubMed ID: 10543292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revisited physicochemical and transport properties of respiratory mucus in genotyped cystic fibrosis patients.
    Deneuville E; Perrot-Minot C; Pennaforte F; Roussey M; Zahm JM; Clavel C; Puchelle E; de Bentzmann S
    Am J Respir Crit Care Med; 1997 Jul; 156(1):166-72. PubMed ID: 9230742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the physiochemical properties of mucus in the protection of the respiratory epithelium.
    Girod S; Zahm JM; Plotkowski C; Beck G; Puchelle E
    Eur Respir J; 1992 Apr; 5(4):477-87. PubMed ID: 1563506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model of mucociliary clearance in cystic fibrosis lungs.
    Kurbatova P; Bessonov N; Volpert V; Tiddens HA; Cornu C; Nony P; Caudri D;
    J Theor Biol; 2015 May; 372():81-8. PubMed ID: 25746843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoring airway surface liquid in cystic fibrosis.
    Ratjen F
    N Engl J Med; 2006 Jan; 354(3):291-3. PubMed ID: 16421371
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of phospholipid lining on respiratory mucus clearance by cough.
    Girod S; Galabert C; Pierrot D; Boissonnade MM; Zahm JM; Baszkin A; Puchelle E
    J Appl Physiol (1985); 1991 Dec; 71(6):2262-6. PubMed ID: 1778921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of a first-generation antihistamine on sputum viscoelasticity in cystic fibrosis.
    Homnick DN; Marks JH; Rubin BK
    J Aerosol Med; 2007; 20(1):45-9. PubMed ID: 17388752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.